bioRxivBiochemistry
Cryo-EM structures of SARS-CoV-2 Omicron BA.2 spike
V. Stalls, J. Lindenberger, S. Gobeil, R. Henderson, R. Parks, M. Barr, M. Deyton, M. Martin, K. Janowska, X. Huang, A. May, M. Speakman, E. Beaudoin, B. Kraft, X. Lu, R. J. Edwards, A. Eaton, D. Montefiori, W. Williams, K. O. Saunders, K. Wiehe, B. F. Haynes, P. Acharya
Abstract
The BA.2 sub-lineage of the SARS-CoV-2 Omicron variant has gained in proportion relative to BA.1. As differences in spike (S) proteins may underlie differences in their pathobiology, here we determine cryo-EM structures of a BA.2 S ectodomain and compare these to previously determined BA.1 S structures. BA.2 Receptor Binding Domain (RBD) mutations induced remodeling of the internal RBD structure resulting in its improved thermostability and tighter packing within the 3-RBD-down spike. In the S2 subunit, the fusion peptide in BA.2 was less accessible to antibodies than in BA.1. Pseudovirus neutralization and spike binding assays revealed extensive immune evasion while defining epitopes of two RBD-directed antibodies, DH1044 and DH1193, that bound the outer RBD face to neutralize both BA.1 and BA.2. Taken together, our results indicate that stabilization of the 3-RBD-down state through interprotomer RBD-RBD packing is a hallmark of the Omicron variant, and reveal differences in key functional regions in the BA.1 and BA.2 S proteins.
- organism: virus
- assay: cryo-EM
- research focus: protein structure prediction
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Structural basis for antibody resistance to SARS-CoV-2 omicron variant
G. Cerutti, Y. Guo, … L. Shapiro·bioRxiv·Dec 21, 2021
- Structural diversity of the SARS-CoV-2 Omicron spike
S. Gobeil, R. Henderson, … P. Acharya·bioRxiv·Jan 25, 2022
- Molecular basis of SARS-CoV-2 Omicron variant receptor engagement and antibody evasion and neutralization
- Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement
M. McCallum, N. Czudnochowski, … D. Veesler·bioRxiv·Dec 28, 2021
- Structural basis for the enhanced infectivity and immune evasion of Omicron subvariants
- Structural insights for neutralization of BA.1 and BA.2 Omicron variants by a broadly neutralizing SARS-CoV-2 antibody
S. Kumar, A. Patel, … A. Chandele·bioRxiv·May 13, 2022